Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology. (Q43250098)
scientific article published on 2 November 2009
Language:
(P31) (Q13442814)
(P50) (Q56503568)
(P304) 187-189
(P407) (Q1860)
(P433) 1
(P478) 21
(P577) Monday, November 2, 2009
(P921) (Q974135)
(Q19484)
(Q412616)
(P1433) (Q326122)
(P1476) "Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology" (language: en)
(P2093) B Martin-Castillo
J Dorca
A Vazquez-Martin
C Oliveras-Ferraros
E Lopez-Bonet
M Garcia
S Del Barco
other details
description scientific article published on 2 November 2009

External Links